In the current study, given previous documentation of anti-inflammatory and anti-fibrotic characteristics of FTS, the role of Ras and the therapeutic potential of FTS was evaluated in this mouse model of merosin deficient congenital muscular dystrophy. The gene discussed is LAMA2; the disease is congenital muscular dystrophy due to LMNA mutation.